Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 870

1.

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how.

de Bie RMA, Clarke CE, Espay AJ, Fox SH, Lang AE.

Lancet Neurol. 2020 Mar 12. pii: S1474-4422(20)30036-3. doi: 10.1016/S1474-4422(20)30036-3. [Epub ahead of print] Review.

PMID:
32171387
2.

Opinions and clinical practices related to diagnosing and managing functional (psychogenic) movement disorders: changes in the last decade.

LaFaver K, Lang AE, Stone J, Morgante F, Edwards M, Lidstone S, Maurer CW, Hallett M, Dwivedi AK, Espay AJ.

Eur J Neurol. 2020 Mar 9. doi: 10.1111/ene.14200. [Epub ahead of print]

PMID:
32153070
3.

Outcome measurement in functional neurological disorder: a systematic review and recommendations.

Pick S, Anderson DG, Asadi-Pooya AA, Aybek S, Baslet G, Bloem BR, Bradley-Westguard A, Brown RJ, Carson AJ, Chalder T, Damianova M, David AS, Edwards MJ, Epstein SA, Espay AJ, Garcin B, Goldstein LH, Hallett M, Jankovic J, Joyce EM, Kanaan RA, Keynejad RC, Kozlowska K, LaFaver K, LaFrance WC Jr, Lang AE, Lehn A, Lidstone S, Maurer CW, Mildon B, Morgante F, Myers L, Nicholson C, Nielsen G, Perez DL, Popkirov S, Reuber M, Rommelfanger KS, Schwingenshuh P, Serranova T, Shotbolt P, Stebbins GT, Stone J, Tijssen MA, Tinazzi M, Nicholson TR.

J Neurol Neurosurg Psychiatry. 2020 Feb 28. pii: jnnp-2019-322180. doi: 10.1136/jnnp-2019-322180. [Epub ahead of print] Review.

4.

Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, Strafella AP, Singleton AB, Barker RA, Kieburtz K, Olanow CW, Lozano A, Kordower JH, Cedarbaum JM, Brundin P, Standaert DG, Lang AE.

Neurology. 2020 Mar 17;94(11):481-494. doi: 10.1212/WNL.0000000000009107. Epub 2020 Feb 26. Review.

PMID:
32102975
5.

Integrated Therapy for Functional Movement Disorders: Time for a Change.

Lidstone SC, MacGillivray L, Lang AE.

Mov Disord Clin Pract. 2020 Jan 11;7(2):169-174. doi: 10.1002/mdc3.12888. eCollection 2020 Feb. No abstract available.

PMID:
32071934
6.

Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?

Bally JF, Breen DP, Schaake S, Trinh J, Rakovic A, Klein C, Lang AE.

Parkinsonism Relat Disord. 2020 Feb;71:44-45. doi: 10.1016/j.parkreldis.2020.01.017. Epub 2020 Jan 30.

7.

Late-Onset Mitochondrial Membrane Protein-Associated Neurodegeneration With Extensive Brain Iron Deposition.

Alavi A, Mokhtari M, Hajati R, Davarzani A, Fasano A, Lang AE, Rohani M.

Mov Disord Clin Pract. 2019 Nov 30;7(1):120-121. doi: 10.1002/mdc3.12868. eCollection 2020 Jan. No abstract available.

PMID:
31970231
8.

Author response: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

Espay AJ, Vizcarra JA, Marsili L, Lang AE, Sardi SP, Leverenz JB.

Neurology. 2020 Jan 21;94(3):144-145. doi: 10.1212/WNL.0000000000008822. No abstract available.

PMID:
31959685
9.

Association Between Social Cognition Changes and Resting State Functional Connectivity in Frontotemporal Dementia, Alzheimer's Disease, Parkinson's Disease, and Healthy Controls.

Multani N, Taghdiri F, Anor CJ, Varriano B, Misquitta K, Tang-Wai DF, Keren R, Fox S, Lang AE, Vijverman AC, Marras C, Tartaglia MC.

Front Neurosci. 2019 Nov 22;13:1259. doi: 10.3389/fnins.2019.01259. eCollection 2019.

10.

Advance care planning in Parkinson's disease: ethical challenges and future directions.

Sokol LL, Young MJ, Paparian J, Kluger BM, Lum HD, Besbris J, Kramer NM, Lang AE, Espay AJ, Dubaz OM, Miyasaki JM, Matlock DD, Simuni T, Cerf M.

NPJ Parkinsons Dis. 2019 Nov 22;5:24. doi: 10.1038/s41531-019-0098-0. eCollection 2019. Review.

11.

Corticobasal degeneration.

Saranza GM, Whitwell JL, Kovacs GG, Lang AE.

Int Rev Neurobiol. 2019;149:87-136. doi: 10.1016/bs.irn.2019.10.014. Epub 2019 Nov 21.

PMID:
31779825
12.

Hallucinations, Delusions and Impulse Control Disorders in Parkinson Disease.

Lizarraga KJ, Fox SH, Strafella AP, Lang AE.

Clin Geriatr Med. 2020 Feb;36(1):105-118. doi: 10.1016/j.cger.2019.09.004. Epub 2019 Sep 6. Review.

PMID:
31733691
13.

Interhemispheric pathways in agenesis of the corpus callosum and Parkinson's disease.

Lizarraga KJ, Saravanamuttu J, Baarbé JK, Lang AE, Chen R.

Brain Stimul. 2020 Mar - Apr;13(2):360-362. doi: 10.1016/j.brs.2019.11.003. Epub 2019 Nov 4. No abstract available.

14.

Impingement pain affects kinematics of breast cancer survivors in work-related functional tasks.

Lang AE, Dickerson CR, Kim SY, Stobart J, Milosavljevic S.

Clin Biomech (Bristol, Avon). 2019 Dec;70:223-230. doi: 10.1016/j.clinbiomech.2019.10.001. Epub 2019 Oct 19.

PMID:
31669920
15.

What Is the Role of a Specialist Assessment Clinic for FND? Lessons From Three National Referral Centers.

Aybek S, Lidstone SC, Nielsen G, MacGillivray L, Bassetti CL, Lang AE, Edwards MJ.

J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):79-84. doi: 10.1176/appi.neuropsych.19040083. Epub 2019 Oct 7.

PMID:
31587627
16.

Clinical and neural responses to cognitive behavioral therapy for functional tremor.

Espay AJ, Ries S, Maloney T, Vannest J, Neefus E, Dwivedi AK, Allendorfer JB, Wulsin LR, LaFrance WC, Lang AE, Szaflarski JP.

Neurology. 2019 Nov 5;93(19):e1787-e1798. doi: 10.1212/WNL.0000000000008442. Epub 2019 Oct 4. Erratum in: Neurology. 2020 Mar 10;94(10):459.

PMID:
31586023
17.

Tics and functional tic-like movements: Can we tell them apart?

Ganos C, Martino D, Espay AJ, Lang AE, Bhatia KP, Edwards MJ.

Neurology. 2019 Oct 22;93(17):750-758. doi: 10.1212/WNL.0000000000008372. Epub 2019 Sep 24. Review.

PMID:
31551261
18.

ADCY5-Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder.

Vijiaratnam N, Bhatia KP, Lang AE, Raskind WH, Espay AJ.

Mov Disord Clin Pract. 2019 Aug 19;6(7):512-520. doi: 10.1002/mdc3.12816. eCollection 2019 Sep. Review.

PMID:
31538084
19.

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities.

Visanji NP, Lang AE, Kovacs GG.

Transl Neurodegener. 2019 Sep 4;8:28. doi: 10.1186/s40035-019-0172-x. eCollection 2019. Review.

20.

Orthostatic hypotension and dementia incidence: links and implications.

Robertson AD, Udow SJ, Espay AJ, Merola A, Camicioli R, Lang AE, Masellis M.

Neuropsychiatr Dis Treat. 2019 Aug 2;15:2181-2194. doi: 10.2147/NDT.S182123. eCollection 2019.

21.

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.

Carricarte Naranjo C, Marras C, Visanji NP, Cornforth DJ, Sanchez-Rodriguez L, Schüle B, Goldman SM, Estévez M, Stein PK, Lang AE, Jelinek HF, Machado A.

Clin Auton Res. 2019 Dec;29(6):603-614. doi: 10.1007/s10286-019-00632-w. Epub 2019 Aug 23.

PMID:
31444591
22.

Cortical GABAergic dysfunction underlying abnormal hand movements in ARX mutation.

Lizarraga KJ, Baarbé JK, Saravanamuttu J, Lang AE, Chen R.

Clin Neurophysiol. 2019 Oct;130(10):1750-1751. doi: 10.1016/j.clinph.2019.07.003. Epub 2019 Jul 16. No abstract available.

PMID:
31400578
23.

Gelastic Cataplexy in Niemann Pick Type C.

Yazdi N, Fasano A, Lang AE, Rohani M.

Mov Disord Clin Pract. 2019 Jun 26;6(6):498-499. doi: 10.1002/mdc3.12786. eCollection 2019 Jul. No abstract available.

PMID:
31392255
24.

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Ghadery C, Koshimori Y, Christopher L, Kim J, Rusjan P, Lang AE, Houle S, Strafella AP.

Mol Neurobiol. 2020 Jan;57(1):492-501. doi: 10.1007/s12035-019-01714-6. Epub 2019 Aug 5.

PMID:
31385228
25.

Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.

Saeedi Y, Kazemi F, Habibi SAH, Tafakhori A, Chitsaz A, Fasano A, Lang AE, Rohani M.

Pediatr Neurol. 2019 Jun 13. pii: S0887-8994(19)30391-1. doi: 10.1016/j.pediatrneurol.2019.06.004. [Epub ahead of print]

PMID:
31371123
26.

Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.

Al-Shorafat DM, Lang AE.

Can J Neurol Sci. 2019 Nov;46(6):782-784. doi: 10.1017/cjn.2019.251. No abstract available.

PMID:
31366412
27.

Deep brain stimulation in status dystonicus caused by anti-NMDA receptor encephalitis.

Tavasoli AR, Shahidi G, Parvaresh M, Fasano A, Ashrafi MR, Hosseinpour S, Lang AE, Rohani M.

Parkinsonism Relat Disord. 2019 Sep;66:255-257. doi: 10.1016/j.parkreldis.2019.07.023. Epub 2019 Jul 20. No abstract available.

PMID:
31345707
28.

Isolated Abdominal Motor Seizures of Mesial Parietal Origin: Epileptic Belly Dancing?

Lizarraga KJ, Serrano EA, Tornes L, Kanner AM, Lang AE.

Mov Disord Clin Pract. 2019 Apr 19;6(5):396-399. doi: 10.1002/mdc3.12762. eCollection 2019 Jun. No abstract available.

PMID:
31286010
29.

Dancing Dorsal Quadrilaterals-Organic or Functional?-Reply.

Lizarraga KJ, Thompson PD, Lang AE.

JAMA Neurol. 2019 Jul 1. doi: 10.1001/jamaneurol.2019.1720. [Epub ahead of print] No abstract available.

PMID:
31260001
30.

The clinical significance of lower limb tremors.

Rajalingam R, Breen DP, Chen R, Fox S, Kalia LV, Munhoz RP, Slow E, Strafella AP, Lang AE, Fasano A.

Parkinsonism Relat Disord. 2019 Aug;65:165-171. doi: 10.1016/j.parkreldis.2019.06.007. Epub 2019 Jun 8.

PMID:
31201091
31.

Parkinson's disease in the Western Pacific Region.

Lim SY, Tan AH, Ahmad-Annuar A, Klein C, Tan LCS, Rosales RL, Bhidayasiri R, Wu YR, Shang HF, Evans AH, Pal PK, Hattori N, Tan CT, Jeon B, Tan EK, Lang AE.

Lancet Neurol. 2019 Sep;18(9):865-879. doi: 10.1016/S1474-4422(19)30195-4. Epub 2019 Jun 4. Review.

PMID:
31175000
32.

Hiding in Plain Sight: Functional Neurological Disorders in the News.

Popkirov S, Nicholson TR, Bloem BR, Cock HR, Derry CP, Duncan R, Dworetzky BA, Edwards MJ, Espay AJ, Hallett M, Lang AE, Leach JP, Lehn A, McGonigal A, Morgante F, Perez DL, Reuber M, Richardson MP, Smith P, Stamelou M, Tijssen MAJ, Tinazzi M, Carson AJ, Stone J.

J Neuropsychiatry Clin Neurosci. 2019 Fall;31(4):361-367. doi: 10.1176/appi.neuropsych.19010025. Epub 2019 May 23.

PMID:
31117907
33.

Dystonia and Parkinson's disease: What is the relationship?

Shetty AS, Bhatia KP, Lang AE.

Neurobiol Dis. 2019 Dec;132:104462. doi: 10.1016/j.nbd.2019.05.001. Epub 2019 May 9. Review.

34.

Jumping to overcome freezing of gait while turning in Parkinson's disease.

Lizarraga KJ, Gnanamanogaran B, Fasano A, Lang AE.

Parkinsonism Relat Disord. 2019 Jul;64:349-351. doi: 10.1016/j.parkreldis.2019.04.021. Epub 2019 Apr 30. No abstract available.

PMID:
31076266
35.

Paroxysmal Asymmetric Dystonic Arm Posturing-A Less Recognized but Characteristic Manifestation of ATP1A3-related disease.

Balint B, Stephen CD, Udani V, Sankhla CS, Barad NH, Lang AE, Bhatia KP.

Mov Disord Clin Pract. 2019 Apr 4;6(4):312-315. doi: 10.1002/mdc3.12747. eCollection 2019 Apr.

PMID:
31061839
36.

Isolated lingual myoclonus in an HIV patient.

Ameghino L, Marrodan M, Lang AE, Merello M.

Parkinsonism Relat Disord. 2019 Apr;61:241-244. doi: 10.1016/j.parkreldis.2018.10.020. Epub 2018 Oct 15. No abstract available.

PMID:
31036159
37.

Tremor with congenital mirror movements: evidence of involvement of the primary motor cortex in tremor.

Isayama R, Chen R, Lang AE, Deuschl G, Fasano A.

Eur J Neurol. 2019 Jun;26(6):e66-e67. doi: 10.1111/ene.13901. No abstract available.

PMID:
31034740
38.

The utility of the acromion marker cluster (AMC) in a clinical population.

Lang AE, Kim SY, Milosavljevic S, Dickerson CR.

J Electromyogr Kinesiol. 2019 Apr 15:102298. doi: 10.1016/j.jelekin.2019.04.002. [Epub ahead of print]

PMID:
31006518
39.

The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.

Vizcarra JA, Sánchez-Ferro Á, Maetzler W, Marsili L, Zavala L, Lang AE, Martinez-Martin P, Mestre TA, Reilmann R, Hausdorff JM, Dorsey ER, Paul SS, Dexheimer JW, Wissel BD, Fuller RLM, Bonato P, Tan AH, Bloem BR, Kopil C, Daeschler M, Bataille L, Kleiner G, Cedarbaum JM, Klucken J, Merola A, Goetz CG, Stebbins GT, Espay AJ; MDS Technology Task Force and the MDS Rating Scales Program Electronic Development Ad-Hoc Committee.

Mov Disord. 2019 May;34(5):676-681. doi: 10.1002/mds.27673. Epub 2019 Mar 22. No abstract available.

PMID:
30901492
40.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2019 Aug;34(8):1228-1232. doi: 10.1002/mds.27666. Epub 2019 Mar 18.

41.

Reader response: IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease.

Bally JF, Lang AE.

Neurology. 2019 Mar 12;92(11):544. doi: 10.1212/WNL.0000000000007087. No abstract available.

PMID:
30858247
42.

Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindred.

Balint B, Lang AE.

Parkinsonism Relat Disord. 2019 Feb 19. pii: S1353-8020(19)30070-7. doi: 10.1016/j.parkreldis.2019.02.024. [Epub ahead of print] No abstract available.

PMID:
30858069
43.

Smoldering Multiple Myeloma Associated Leukoencephalopathy Presenting with Holmes Tremor, Ataxia, and Pyramidal Syndrome.

Aquino CC, Connolly B, Lang AE.

Mov Disord Clin Pract. 2018 Jul 19;5(4):433-435. doi: 10.1002/mdc3.12623. eCollection 2018 Jul-Aug. No abstract available.

44.

Successful spinal cord stimulation for severe medication-refractory restless legs syndrome.

De Vloo P, Reddy GD, Rowland N, Sammartino F, Llinas M, Paul D, Murray BJ, Lang AE, Fasano A, Munhoz RP, Kalia SK.

Mov Disord. 2019 Apr;34(4):585-586. doi: 10.1002/mds.27644. Epub 2019 Feb 15. No abstract available.

PMID:
30768799
45.

Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism.

Freitas ME, Alqaraawi A, Lang AE, Liu LWC.

Mov Disord Clin Pract. 2018 Jan 28;5(2):218-220. doi: 10.1002/mdc3.12577. eCollection 2018 Mar-Apr. No abstract available.

46.

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB.

Neurology. 2019 Feb 12;92(7):329-337. doi: 10.1212/WNL.0000000000006926. Review.

47.

Diagnostic delay in Parkinson's disease caused by PRKN mutations.

Ruiz-Lopez M, Freitas ME, Oliveira LM, Munhoz RP, Fox SH, Rohani M, Rogaeva E, Lang AE, Fasano A.

Parkinsonism Relat Disord. 2019 Jun;63:217-220. doi: 10.1016/j.parkreldis.2019.01.010. Epub 2019 Jan 10.

PMID:
30692050
48.

Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.

Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA; LEAP Study Group.

N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983.

PMID:
30673543
49.

Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes".

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C.

Parkinsonism Relat Disord. 2019 Sep;66:245-246. doi: 10.1016/j.parkreldis.2018.12.028. Epub 2018 Dec 28. No abstract available.

PMID:
30655161
50.

Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?

Breen DP, Halliday GM, Lang AE.

Mov Disord. 2019 Mar;34(3):307-316. doi: 10.1002/mds.27556. Epub 2019 Jan 17. Review.

PMID:
30653258

Supplemental Content

Support Center